Significant Generics Opportunity

Source: IMS and analyst reports; internal McKesson analysis

Branded pharmaceuticals going off patent

Should drive significant generic growth and margin expansion

• Select Generics program

• 20,000 pharmacy outlets

• Generic Rx GP higher than that

of branded Rx

Previous slide

Next slide

Back to first slide

View graphic version